MedTrace Logo

A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin Cancer

NCT05602337 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2022-11-02

No results posted yet for this study

Summary

This is a prospective, multicenter, sample collection study using DermTech's non-invasive skin collection kits to evaluate the mutation burden of non-lesional facial skin from subjects with a documented history of numerous basal cell carcinomas, squamous cell carcinomas or melanomas compared to that of subjects with no history of skin cancer matched for age, sex and Fitzpatrick phototype.

Conditions

  • Melanoma and Other Malignant Neoplasms of Skin

Interventions

OTHER

Observational Study Only

Non-invasive Skin Sampling

Sponsors & Collaborators

  • University of Pittsburgh

    collaborator OTHER

  • DermTech

    lead OTHER

Principal Investigators

  • James Rock · DermTech

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-15
Primary Completion
2024-11-15
Completion
2025-03-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05602337 on ClinicalTrials.gov